Search hospitals
>
Colorado
>
Denver
Rocky Mountain Cancer Centers-Midtown
Claim this profile
Denver, Colorado 80218
Global Leader in Lung Cancer
Global Leader in Breast Cancer
Conducts research for Cancer
Conducts research for Pancreatic Cancer
Conducts research for Colorectal Cancer
388 reported clinical trials
10 medical researchers
Summary
Rocky Mountain Cancer Centers-Midtown is a medical facility located in Denver, Colorado. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Pancreatic Cancer, Colorectal Cancer and other specialties. Rocky Mountain Cancer Centers-Midtown is involved with conducting 388 clinical trials across 468 conditions. There are 10 research doctors associated with this hospital, such as Nicholas DiBella, Allen L. Cohn, Manojkumar Bupathi, MD, MS, and John M. Burke, MD.
Area of expertise
Lung Cancer
Rocky Mountain Cancer Centers-Midtown has run 75 trials for Lung Cancer. Some of their research focus areas include:
Breast Cancer
Rocky Mountain Cancer Centers-Midtown has run 70 trials for Breast Cancer. Some of their research focus areas include:
Top PIs
Nicholas DiBella
Rocky Mountain Cancer Centers-Boulder
7 years of reported clinical research
Allen L. Cohn
Rocky Mountain Cancer Centers
3 years of reported clinical research
Manojkumar Bupathi, MD, MS
Rocky Mountain Cancer Center
1 year of reported clinical research
John M. Burke, MD
Rocky Mountain Cancer Centers - Aurora
13 years of reported clinical research
Clinical Trials running at Rocky Mountain Cancer Centers-Midtown
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Cancer
Pancreatic Cancer
Breast cancer
Melanoma
Bladder Cancer
Esophageal cancer
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting
2 awards
Phase 3
47 criteria
Giredestrant vs. Fulvestrant
for Advanced Breast Cancer
This trial is testing two drug combinations to treat a specific type of advanced breast cancer that no longer responds to standard hormone treatments. The goal is to see which combination works better by stopping the cancer cells from growing.
Recruiting
2 awards
Phase 3
8 criteria
Ribociclib + Hormone Therapy
for Breast Cancer
The purpose of this open-label, multicenter, phase IIIb, single-arm study is to characterize the efficacy and safety of the combination of ribociclib and standard adjuvant endocrine therapy (ET) on invasive breast cancer-free survival (iBCFS), in a close to clinical practice patient population with HR-positive (HR+), HER2-negative (HER2-), Anatomic Stage Group III, IIB, and a subset of Stage IIA Early Breast Cancer (EBC).
Recruiting
2 awards
Phase 3
4 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Rocky Mountain Cancer Centers-Midtown?
Rocky Mountain Cancer Centers-Midtown is a medical facility located in Denver, Colorado. This center is recognized for care of Lung Cancer, Breast Cancer, Cancer, Pancreatic Cancer, Colorectal Cancer and other specialties. Rocky Mountain Cancer Centers-Midtown is involved with conducting 388 clinical trials across 468 conditions. There are 10 research doctors associated with this hospital, such as Nicholas DiBella, Allen L. Cohn, Manojkumar Bupathi, MD, MS, and John M. Burke, MD.
Where is Rocky Mountain Cancer Centers-Midtown located?
The Rocky Mountain Cancer Centers-Midtown is situated at 1800 N. Williams St., Ste. 200, Denver, CO 80218. It is conveniently located near HealthOne Presbyterian St. Luke’s Medical Center and Exempla St. Joseph Hospital. For access, head east on N. Williams St. from downtown Denver and turn right into the parking lot before reaching 18th Ave.
Who should I call to ask about financial aid or insurance network?
For financial assistance and insurance inquiries at Rocky Mountain Cancer Centers-Midtown, call (303) 388-4876. Financial counselors are on hand to assist with understanding treatment costs and establishing a financial plan. Update insurance information via their electronic form or directly contact your clinic to confirm network status with your provider.
What insurance does Rocky Mountain Cancer Centers-Midtown accept?
Rocky Mountain Cancer Centers-Midtown accepts a variety of insurance plans, including but not limited to Aetna, Anthem BCBS Colorado, Apostrophe Health, Cigna, Colorado Access, First Health, and Humana Medicare Advantage. They strive to provide access to their facilities for as many individuals as possible and are in-network for most insurance plans. It is crucial to contact both your insurance provider and the clinic to confirm network status and understand your specific coverage.
What awards or recognition has Rocky Mountain Cancer Centers-Midtown received?
Rocky Mountain Cancer Centers-Midtown, located in Denver, Colorado, is renowned for its personalized, world-class cancer care, with a remarkable 90% of patients recommending it. The center has contributed to over 100 FDA-approved cancer therapies. It provides a comprehensive range of treatments and services, including clinical research trials.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.